Does XXXX during percutaneous nephrolithotomy necessitate keeping the @entity5274 ? A randomized controlled clinical trial.

@entity1 @entity5274 @entity548
PURPOSE: To compare outcomes in two groups of @entity1 with kept and discarded @entity5274 after percutaneous nephrolithotomy (PCNL) complicated with @entity548 . MATERIALS AND METHODS: Two hundred @entity1 who had undergone PCNL complicated with @entity548 were recruited in this study. @entity1 were randomly allocated to two groups: group A, who underwent tubeless PCNL and tract port was packed for 3 to 4 minutes after removing Amplatz sheath, and group B, for whom a 24-F @entity5274 was left in place at the end of the procedure. @entity1 were followed up for 3 months to check if @entity548 occurred. RESULTS: The mean operation time was 68    4.3 minutes in group A and 74    5.6 minutes in group B (P = .098). The mean stone size was similar in groups A and B (36.26    5.3 mm versus 35.35    5.85 mm; P = .613). The mean hemoglobin drop was 3.65    1.20 g/dL in group A and 3.13    1.06 g/dL in group B. There was no significant difference between the mean of stone free rate in groups A and B (92.58%    5.97 versus 89.60%    8.3; P = .210). @entity1 in group A experienced a significantly less duration of hospitalization than group B (2.42    0.84 days versus 3.70    0.80 days; P < .001). CONCLUSION: In the absence of clear indication, @entity5274 insertion after PCNL does not seem to be beneficial, and its removal does not pose @entity1 at any additional risk.
